FINRA's Regulation SHO (Reg SHO) data does not explicitly

New Post Public Reply Private Reply Replies (3) Message Board
biloxiblues Ramjet #147215
616
FINRA's Regulation SHO (Reg SHO) data does not explicitly show naked short selling, but it does provide information that could indicate such activity. Reg SHO focuses on regulating short selling practices, including the requirements for marking short sales, locating shares for borrowing, and handling failures to deliver (FTDs) in the settlement process.

Here’s how it works:

Short Interest Data: FINRA publishes short interest data, which reflects the total number of shares sold short but not yet covered or closed out. This data doesn't show naked shorting directly but gives an idea of how much short selling is occurring in the market.

Threshold Securities List: Reg SHO mandates that FINRA publishes a Threshold Securities List, which shows stocks that have had a high number of "failures to deliver" (FTDs) for five consecutive settlement days. A high number of FTDs can be a red flag for possible naked short selling, but it doesn’t confirm it. FTDs can also result from other reasons, such as technical errors, delays, or legitimate short selling.

Failure-to-Deliver Data (FTDs): The SEC provides FTD data, which is useful for detecting potential naked shorting. Naked short selling occurs when shares are sold short without locating and borrowing the shares, leading to delivery failures. Persistent and high FTD levels in a stock can suggest naked short selling is happening, but the data alone doesn't conclusively prove it.

Naked Short Selling and Reg SHO
Reg SHO was implemented to curb abuses like naked short selling by enforcing the "locate" and "close-out" requirements:

Locate requirement: Brokers must confirm they can borrow or have a good faith reason to believe the security can be borrowed before making a short sale.
Close-out requirement: Brokers are required to close out FTDs for securities on the threshold list within a certain time period to prevent indefinite settlement failures.
In summary, while FINRA's Reg SHO data doesn't directly label naked short selling, FTDs and the presence of stocks on the threshold list can offer indirect clues that such activities might be happening.


Read when you have time how they almost destroyed Overstock.com




The case of Overstock.com is one of the most prominent examples where allegations of naked short selling played a significant role in the company's history. The Overstock saga, which spanned the mid-2000s, involved legal battles, market manipulations, and accusations of abusive naked short selling.

Background
Overstock.com, an online retail company founded by Patrick Byrne, became entangled in a complex situation involving allegations that hedge funds and Wall Street institutions were using naked short selling to manipulate the company’s stock price. Naked short selling, as mentioned earlier, occurs when short sellers sell shares without actually borrowing or locating them, which can drive the stock price down by flooding the market with phantom shares.

Here’s a breakdown of what happened:

Allegations and Byrne's Stand
Patrick Byrne’s Allegations: Byrne was outspoken in his belief that naked short sellers were targeting Overstock to drive down its stock price artificially. He argued that these market manipulations were a concerted effort by certain hedge funds, research firms, and media outlets to undermine Overstock’s business and value. He dubbed this alleged conspiracy “the Sith Lord” theory, referring to unknown and powerful forces that were manipulating the stock.

Lawsuits: Overstock.com and Byrne filed lawsuits against various Wall Street firms, alleging a coordinated effort to manipulate the stock price via naked short selling. The most notable lawsuit was filed against prime brokers like Goldman Sachs and Morgan Stanley, accusing them of facilitating and profiting from naked short sales.

In 2016, Overstock settled its case against Goldman Sachs for $20 million. However, the legal battles revealed the extent to which firms were using loopholes in the system, and it raised awareness about the practice of naked short selling in the broader financial industry.

Reg SHO and Overstock: Overstock’s battle came during a time when Reg SHO had been implemented (in 2005), but Patrick Byrne and others argued that it wasn’t enough to stop abusive practices. Overstock frequently appeared on the threshold securities list, indicating a high number of failures to deliver (FTDs). Overstock and Byrne used this data to bolster their claims of naked short selling.

Market Reaction and Publicity: The Overstock case brought naked short selling into the public spotlight. Many market participants had been unaware of how significant the impact of naked shorting could be until Byrne’s campaign. The case received media attention and contributed to discussions on market transparency and the effectiveness of regulations like Reg SHO.

Overstock's Crypto Dividend (2019)
In a later move to combat naked short selling, Byrne, still CEO of Overstock at the time, devised a crypto dividend strategy. In 2019, Overstock issued a digital security dividend that could only be traded on a blockchain-based platform. The idea was to make it more difficult for naked short sellers to locate and deliver shares, as the dividend required ownership of Overstock shares to receive the digital token.

This move was seen as an attempt to squeeze short sellers, and it caused a significant increase in Overstock’s stock price temporarily as short sellers rushed to cover their positions. However, there was also pushback from regulators, and the SEC required more scrutiny of such blockchain-based dividends.

Key Takeaways
Patrick Byrne’s fight against naked short selling is one of the most well-known cases in modern finance, highlighting the potential for abuse within the short-selling and naked short-selling practices.

Overstock’s case was instrumental in bringing more attention to the failures of Regulation SHO to fully curtail naked short selling and the loopholes that existed within the system.

Legal and Financial Impact: Overstock’s legal actions and public campaigns were costly, but they also succeeded in securing settlements from major financial institutions and pushing reforms that aimed to protect companies from predatory market manipulation tactics.

In conclusion, the Overstock.com case is a hallmark of the naked short selling debate, showing how alleged manipulation can affect a company’s stock and spark broader regulatory conversations.



CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 10

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Microbot Medical Secures $13 Million in Recent Offering

Updated Category News Views 92

Microbot Medical Makes Strategic Move with $13 Million Offering Microbot Medical Inc. (NASDAQ: MBOT) has recently taken an important step to elevate its operations by entering into definitive agreements to sell 6,103,289 shares of its common stock at a price of $2.13 per share. This registered direct offering, priced at-the-market under Nasdaq rules, underscores the...

Continue Reading
Evolv Technologies Faces Class Action Lawsuit: Know Your Rights

Updated Category News Views 651

Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...

Continue Reading
Rhino Rescue Unveils Innovative First Aid Kits for Adventurers

Updated Category News Views 117

Rhino Rescue Launches Innovative Products for Outdoor Safety Rhino Rescue has made a remarkable stride in enhancing outdoor safety with its new lineup of first aid kits targeted towards adventurers and everyday users alike. The release of the Rhino Rescue Mini First Aid Kit, along with home and camping-specific options, marks an exciting development in the company’s...

Continue Reading
RUSH's 2026 Tour: Celebrating Legacy and New Beginnings

Updated Category News Views 258

RUSH's 2026 Tour: A Celebration of Music and Legacy Geddy Lee and Alex Lifeson are set to celebrate over 50 years of RUSH's musical journey as they announce a special headline tour for 2026, named the Fifty Something Tour. This tour not only commemorates the incredible music and legacy of RUSH, but also pays tribute to their late drummer and lyricist Neil Peart, whose...

Continue Reading
BioSyent Inc. Announces Quarterly Dividend for Shareholders

Updated Category News Views 132

BioSyent Inc. Announces Quarterly Dividend for Shareholders MISSISSAUGA, Ontario — BioSyent Inc. (TSX Venture: RX) is thrilled to communicate that its Board of Directors has approved a quarterly dividend of $0.05 per common share. This dividend will be paid in Canadian Dollars on a specified date to shareholders who are on record, enhancing the company's ongoing...

Continue Reading